Genoa acquires Advanced Pharmacy Solutions

1/4/2017

TUKWILA, Wash. — Genoa is starting its year off by expanding its footprint, announcing Wednesday the acquisition of Mississippi-based Advanced Pharmacy Solutions. With the acquisition, Genoa’s will enter Miss., Tenn., Ark., and S.C., serving 50 additional clinics with its approach to behavioral health that integrates the pharmacists into a patient’s care team in an effort to improve outcomes and reduce costs. 


 


“Genoa and APS share a common mission of improving the lives of individuals living with mental illness, while providing solutions to our clinic partners who serve them,” Genoa CEO John Figueroa said. “This addition allows us to combine our expertise and best practices to better serve consumers and our partner mental health centers. We look forward to bringing even more value and innovative solutions to our partners and consumers.”


 


The companies said the combination is a good fit, given their shared goals of providing high-touch care to patients. 


 


“Over the past seven years APS has worked to build a team that is passionate about and committed to serving the unique needs of patients with mental illness, Community Mental Health Centers, and behavioral health hospitals,” APS CEO Mark Bradford said. “During that time we've grown from caring for a few hundred patients in Mississippi to several thousand patients throughout the Mid-South and Southeast. We're pleased to be partnering with Genoa. Our core values are in alignment, and we share the same passion and commitment to patient care and client service.  We're particularly excited to know our employees, patients, and clients will have access to more resources and cutting edge technology than ever before.”


 


The news comes following the recent publication of a study of patients at Community Mental Health Centers with Genoa’s onsite pharmacy that was published in the November 2016 edition of The Journal of Managed Care & Specialty Pharmacy. The study found higher adherence rates and lower rates of hospitalization related to behavioral health and emergency department visits among those patients whose CMHC used a Genoa pharmacy, when compared to patients at a community pharmacy. 


 


“This peer-reviewed study validates Genoa's positive impact on patients' lives and reflects our team's commitment to working with our community mental health center partners to improve outcomes and reduce healthcare costs,” Figueroa said. “The APS acquisition allows Genoa to expand our reach to help more of the over 40 million Americans with mental illness.”


 


Financial terms of the acquisition were not disclosed. 


 

X
This ad will auto-close in 10 seconds